Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 600x60px
Document › Details

Agilent Technologies Inc.. (6/18/10). "Press Release: Agilent Technologies Launches Bio-Inert LC to Characterize Large Biomolecules, New Biological Entities". Boston, MA.

Region Region Boston, MA
  Country United States (USA)
Products Product 1260 Infinity bio-inert quarternary LC system
  Product 2 BioHPLC column
Persons Person Schütte, Stefan (Agilent 200903 Senior Marketing Director Liquid Chromatography Business)
  Person 2 Matlow, Stuart (Stu) (Thermo Fisher 201206 Public Relations Manager Chromatography + Mass Spectrometry before Agilent)

Agilent Technologies Inc. (NYSE: A) today introduced the 1260 Infinity bio-inert quaternary liquid chromatography (LC) system designed to characterize and confirm large biomolecules, especially new biological entities (NBEs) and therapeutic monoclonal antibodies.

"This new system is a complete solution for addressing the growing demand to analyze NBEs and biosimilars, as drug developers seek to determine safety and efficacy of these complex molecules," said Stefan Schuette, Agilent LC marketing director. "There are huge benefits to increasing robustness and performance significantly for large biomolecule analysis, increasing productivity, uptime and reproducibility. We think users will agree that this new system succeeds."

The system is based on the new Agilent 1260 Infinity LC system with quaternary pump module. It features a completely inert, metal-free sample-flow path, and a stainless steel-free solvent delivery path to protect sample integrity and to minimize unspecific surface interaction and corrosion of the instrument. The system tolerates a very wide pH range from 1 to as high as 14. Agilent also offers a family of BioHPLC ion exchange and size exclusion columns designed for these specific types of analyses, contributing to the robust, reproducible high-resolution performance.

The standard detector and the 600-bar power range combine to provide the lowest detection limits and highest resolution per time for any bio-inert LC-based bioseparation system, from low-pressure methods up through small-particle, high-pressure column technology.
The new Agilent bio-inert LC system can accommodate both bioanalysis and bio-purification tasks, offering analytical flow rates and fraction collection as high as 10 ml/min.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The company's 19,000 employees serve customers in more than 110 countries. Agilent had net revenues of $4.5 billion in fiscal 2009. Information about Agilent is available on the Web at

# # #

For more information, please visit the Press Kit - 1200 Infinity Series Introduction.

Stuart Matlow
+1 408 553 7191

Record changed: 2016-03-19


Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Agilent (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 600x60px

» top


Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 120x180px Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 120x180px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture [LSE] – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px